San Diego, CA, United States of America

Karensa L Douglas

This inventor holds 6 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Genentech, Inc., Metacrine, Inc., Organovo, Inc.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karensa L Douglas. Retrieved from https://idiyas.com/inventor/karensa-l-douglas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Karensa L Douglas

Introduction

Karensa L Douglas is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of farnesoid X receptor agonists. With a total of six patents to her name, her work has the potential to impact the treatment of various medical conditions.

Latest Patents

Among her latest patents, Douglas has developed compounds that act as farnesoid X receptor agonists. These patents describe methods for creating such compounds, as well as pharmaceutical compositions and medicaments that incorporate them. The applications of these compounds are aimed at treating conditions, diseases, or disorders associated with farnesoid X receptor activity.

Career Highlights

Throughout her career, Douglas has worked with notable companies such as Genentech, Inc. and Metacrine, Inc. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation.

Collaborations

Some of her coworkers include Nicholas D Smith and Steven P Govek. Their collaborative efforts have contributed to the advancement of research in her field.

Conclusion

Karensa L Douglas is a trailblazer in the realm of pharmaceutical inventions, with a focus on farnesoid X receptor agonists. Her innovative work continues to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…